SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Feuillet, L
Right arrow Articles by Pelletier, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feuillet, L
Right arrow Articles by Pelletier, J
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Multiple Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis

L Feuillet

F Reuter

B Audoin

I Malikova

Department of Neurology, Faculté de Médecine de Marseille, Université de la Méditerranée, Assistance Publique Hôpitaux de Marseille, Hôpital de La Timone, Marseille, France; CRMBM-CNRS 6612, Faculté de Médecine de Marseille, Université de la Méditerranée, Assistance Publique Hôpitaux de Marseille, Hôpital de La Timone, Marseille, France

K Barrau

Department of Public Health, Faculté de Médecine de Marseille, Université de la Méditerranée, Assistance Publique Hôpitaux de Marseille, Hôpital de La Timone, Marseille, France

A Ali Cherif

Department of Neurology, Faculté de Médecine de Marseille, Université de la Méditerranée, Assistance Publique Hôpitaux de Marseille, Hôpital de La Timone, Marseille, France

J Pelletier

Department of Neurology, Faculté de Médecine de Marseille, Université de la Méditerranée, Assistance Publique Hôpitaux de Marseille, Hôpital de La Timone, Marseille, France; CRMBM-CNRS 6612, Faculté de Médecine de Marseille, Université de la Méditerranée, Assistance Publique Hôpitaux de Marseille, Hôpital de La Timone, Marseille, France; Department of Neurology, CHU Timone, F-13385, Marseille, France; jean.pelletier{at}mail.ap-hm.fr

Cognitive impairment in patients with multiple sclerosis (MS) is a common occurrence and is generally fairly circumscribed. The prevalence of the cognitive deficits usually encountered could vary with the clinical course of the disease. To investigate whether the presence of cognitive impairment may occur in the very early stage of MS, we assessed the cognitive status of a group of 40 patients presenting with a recently diagnosed clinically isolated syndrome suggestive of MS (CISSMS), in comparison with 30 age-, sex-, and educational level-matched healthy control subjects. An extensive battery of neuropsychological tests was used to explore verbal and non-verbal memory, attention, concentration, speed of information processing, language and abstract reasoning. Patients with CISSMS had a significant, frequent (57%), and circumscribed cognitive impairment, focused on memory, speed of information processing, attention and executive functions.

Key Words: biomedical research • clinically isolated syndrome • cognitive impairment • multiple sclerosis • neurobehavioral manifestations • neuropsychological tests • PASAT

Multiple Sclerosis, Vol. 13, No. 1, 124-127 (2007)
DOI: 10.1177/1352458506071196


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
O. Garcea, A. Villa, F. Caceres, T. Adoni, M. Alegria, R. Barbosa Thomaz, R. Buzo, L. Llamas Lopez, and M. Rivera Kindel
Early treatment of multiple sclerosis: a Latin American Experts Meeting
Multiple Sclerosis, October 1, 2009; 15(3_suppl): S1 - S12.
[Abstract] [PDF]


Home page
Therapeutic Advances in Neurological DisordersHome page
F. Patti, M. Pia Amato, S. Bastianello, L. Caniatti, E. Di Monte, F. Lijoi, B. Goretti, S. Messina, O. Picconi, M. R. Tola, et al.
Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing--remitting multiple sclerosis: 2-year results from the COGIMUS study
Therapeutic Advances in Neurological Disorders, March 1, 2009; 2(2): 67 - 77.
[Abstract] [PDF]


Home page
Mult SclerHome page
F Patti
Cognitive impairment in multiple sclerosis
Multiple Sclerosis, January 1, 2009; 15(1): 2 - 8.
[Abstract] [PDF]


Home page
Mult SclerHome page
P Nilsson, I Rorsman, E. Larsson, B Norrving, and M Sandberg-Wollheim
Cognitive dysfunction 24-31 years after isolated optic neuritis
Multiple Sclerosis, August 1, 2008; 14(7): 913 - 918.
[Abstract] [PDF]


Home page
Mult SclerHome page
B Audoin, F Reuter, M. Duong, I Malikova, S Confort-Gouny, A. Cherif, P. Cozzone, J Pelletier, and J. Ranjeva
Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study
Multiple Sclerosis, July 1, 2008; 14(6): 786 - 792.
[Abstract] [PDF]



Advertisement